stage iiia breast cancer

Showing 26 - 50 of 128

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering

Terminated
  • Healthy, no Evidence of Disease
  • +4 more
  • light-scattering spectroscopy
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Nov 11, 2021

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

Ductal Breast Carcinoma, Invasive Breast Carcinoma, Lobular Breast Carcinoma Trial in Canada, United States (Radiation Therapy,

Active, not recruiting
  • Ductal Breast Carcinoma
  • +8 more
  • Radiation Therapy
  • +4 more
  • Anchorage, Alaska
  • +858 more
Oct 1, 2021

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • Birmingham, Alabama
  • +859 more
Jul 19, 2021

Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • Duarte, California
  • +1 more
Jul 9, 2021

HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Duarte (radiation, other,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +3 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +5 more
  • Duarte, California
    City of Hope Medical Center
May 17, 2021

Stage 0 Breast Cancer, Stage I Breast Cancer, Stage IA Breast Cancer Trial in Charlestown, New Brunswick, New York

Completed
  • Stage 0 Breast Cancer
  • +7 more
  • Internet-Based Intervention
  • Survey Administration
  • Charlestown, Massachusetts
  • +2 more
Apr 16, 2021

Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer Trial in Orange (Carboplatin, paclitaxel

Active, not recruiting
  • Breast Cancer
  • +9 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 14, 2021

Cancer Survivor, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in New Brunswick (Behavioral Dietary Intervention,

Completed
  • Cancer Survivor
  • +8 more
  • Behavioral Dietary Intervention
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Robert Wood Johnson Medical School
Apr 9, 2021

Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

Completed
  • Malignant Female Reproductive System Neoplasm
  • +38 more
  • Cognitive Behavior Therapy
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 7, 2021

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer Trial in Los Angeles (Exercise Intervention, Laboratory

Terminated
  • Stage IA Breast Cancer
  • +6 more
  • Exercise Intervention
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Apr 1, 2021

Anxiety Disorder, Depression, Recurrent Breast Cancer Trial in Columbus (minocycline HCl, , laboratory biomarker analysis)

Active, not recruiting
  • Anxiety Disorder
  • +8 more
  • minocycline hydrochloride
  • +3 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jan 14, 2021

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

Unknown status
  • Estrogen Receptor Negative
  • +9 more
  • Chicago, Illinois
  • +1 more
Jun 25, 2020

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago (drug, biological, other)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Chicago, Illinois
    Northwestern University
Jun 25, 2020

Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Columbus (dietary supplement, other, procedure)

Unknown status
  • Recurrent Breast Cancer
  • +6 more
  • omega-3 fatty acid supplement
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2020

Peripheral Neuropathy, Stage 0 Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (procedure, other, diagnostic test)

Completed
  • Peripheral Neuropathy
  • +12 more
  • Biopsy
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
May 8, 2020

Cancer Survivor, No Evidence of Disease, Obesity Trial in Los Angeles (behavioral, other, device)

Terminated
  • Cancer Survivor
  • +15 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
May 9, 2020

Breast Cancer, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Philadelphia (acupuncture therapy, sham intervention)

Completed
  • Breast Cancer
  • +6 more
  • acupuncture therapy
  • sham intervention
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Apr 7, 2020

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Cancer Survivor, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Cleveland (One-on-one interview, Survey Questions)

Completed
  • Cancer Survivor
  • +7 more
  • One-on-one interview
  • Survey Questions
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Jan 2, 2020

Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IA Breast Cancer Trial in Cleveland, Columbus

Unknown status
  • Estrogen Receptor and/or Progesterone Receptor Positive
  • +8 more
  • Cleveland, Ohio
  • +1 more
Dec 18, 2019